Skip to main content
. 2022 Sep 23;13:999704. doi: 10.3389/fimmu.2022.999704

Figure 1.

Figure 1

Trial flow chart. The search identified 1.477 trials for lupus from clinical study databases. After excluding 1.463, 14 randomized control trials (RCTs) were used for this systemic review and meta-analysis in which therapies (anifrolumab, belimumab and rituximab) were tested in both patients with systemic lupus erythematosus (SLE, n = 10) without active lupus nephritis (LN) and with active LN (LN, n = 4) patients. S.c., subcutaneous.